{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-089138","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2026-08-13T20:25:42+00:00","discovered_at":"2026-08-13T20:27:00.420080+00:00","generated_at":"2026-08-13T20:27:17.921597+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenon Medical Q2 revenue up 127% to $1.3M; net loss $4.1M; closes $4.2M offering","bullets":["Q2 revenue $1.3M (+127% YoY); gross profit $0.8M (64% margin vs 43% in Q2 2025).","Net loss $4.1M ($12.35/share) vs $2.8M ($12.76/share) in Q2 2025; cash $1.7M at June 30.","Closed $4.2M public offering July 1, net ~$3.6M; partial repayment of $5.2M convertible notes due Sept 11, 2026.","FDA 510(k) clearance for Catamaran SI Joint Fusion System; record July case volume after 98% training-event increase.","Effected 1-for-35 reverse stock split Aug 10; working to regain Nasdaq minimum bid price compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-089138","json":"https://secwatch.observer/filing/0001213900-26-089138.json","markdown":"https://secwatch.observer/filing/0001213900-26-089138.md","text":"https://secwatch.observer/filing/0001213900-26-089138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/0001213900-26-089138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/ea0301935-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:27:17.921597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}